Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?

Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?

Liver transplant (LT) is the most favorable treatment option for patients with early stage hepatocellular carcinoma (HCC). Numerous attempts have been pursued to establish eligibility criteria and select HCC patients for LT, leading to various systems that essentially integrate clinico-morphological...

Full description

Bibliographic Details
Main Authors: Stéphanie Gonvers, Parissa Tabrizian, Emmanuel Melloul, Olivier Dormond, Myron Schwartz, Nicolas Demartines, Ismail Labgaa
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
CTC (circulation tumor cells)
ctDNA (circulating tumor DNA)
liver cancer
transplant
biomarkers
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.940473/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.940473/full

Similar Items